ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1840

Increased Expression of BAFF Receptor On Monocytes Is a Contributory Factor of Hypergammaglobulinemia in Patients With Primary Sjögren’s Syndrome

Keiko Yoshimoto1, Maiko Tanaka2, Masako Kojima2, Hideko Ogata2, Eriko Ishioka3, Ayumi Nishikawa2, Katsuya Suzuki1, Hideto Kameda1, Tohru Abe4 and Tsutomu Takeuchi5, 1Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, 2Division of Rheumatology and Clinical Immunology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, 3Division of Rheumatology, Department of Internal medicine, Keio University School of Medicine, Tokyo, Japan, 4Dept Int Med Saitama Med Ctr, Saitama Medical School, Kawagoe-shi Saitama, Japan, 5Keio University School of Medicine, Tokyo, Japan

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: BAFF

  • Tweet
  • Email
  • Print
Session Information

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis II

Session Type: Abstract Submissions (ACR)

Background/Purpose: BAFF (B cell stimulation factor belonging to TNF family) is a cytokine which is mainly produced by monocytes, dendritic cells and T cells. We have been investigating the possible involvement of BAFF in the pathogenesis of primary Sjögren’s syndrome (pSS) because BAFF plays a pivotal role in the proliferation, differentiation and survival of B cells. In our previous study, we found that BAFF robustly increased IL-6 production by pSS peripheral monocytes, and the expression level of a BAFF receptor (BAFF-R) was significantly elevated in pSS monocytes compared to that of normal monocytes. These data collectively suggest that the elevated expression of BAFF-R on monocytes is involved in activation of monocytes to promote IL-6 production. Since IL-6 promotes the differentiation of B cells, our findings may provide clues to elucidate the mechanism of the development of pSS. On the other hand, it is well known that pSS is often accompanied by hypergammaglobulinemia (HγG). However, the molecular and cellular mechanism underlying HγG is unknown. In the present study, we focused on this abnormality and investigated the possible involvement of monocytes producing IL-6 in the development of HγG.

Methods: Peripheral monocytes were cultured with or without peripheral B cells and stimulated with soluble BAFF (sBAFF) in vitro. IL-6 production by monocytes and IgG production by B cells were measured by ELISA. FACS analysis of whole blood samples was employed to analyze the expression of BAFF-R.

Results: The serum level of IgG and the proportion of BAFF-R positive monocytes (BR+/CD14+) were elevated in pSS patients as compared to those in normal individuals. Remarkably, the BR+/CD14+ ratio was positively and significantly correlated with the serum IgG level. In addition, pSS monocytes produced a significantly higher amount of IL-6 than normal monocytes upon stimulation with sBAFF in vitro, and the BR+/CD14+ ratio was positively and significantly correlated with the amount of IL-6 produced by pSS monocytes. Stimulation of co-culture of B cells and monocytes with sBAFF drastically enhanced IgG production by B cells in vitro, whereas the stimulation showed only marginal effects on IgG production when B cells were cultured in the absence of monocytes.

Conclusion: The data in the present study collectively suggest that the abnormal expression of BAFF-R on monocytes is responsible for the overproduction of IgG by B cells in pSS patients. IL-6 produced by monocytes may be involved in the differentiation of B cells to produce IgG. We presume that aberrations of monocytes may underlie the development of hypergammaglobulinemia in pSS patients.


Disclosure:

K. Yoshimoto,
None;

M. Tanaka,
None;

M. Kojima,
None;

H. Ogata,
None;

E. Ishioka,
None;

A. Nishikawa,
None;

K. Suzuki,
None;

H. Kameda,
None;

T. Abe,
None;

T. Takeuchi,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-expression-of-baff-receptor-on-monocytes-is-a-contributory-factor-of-hypergammaglobulinemia-in-patients-with-primary-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology